New and emerging combination therapies for esophageal cancer.
about
"Targeted" Chemotherapy for Esophageal CancerThe clinical utility of RFA in esophageal and cardia cancer patients with severe malignant obstruction.Neoadjuvant Therapy for Esophageal Adenocarcinoma in the Community Setting-Practice and Outcomes.Prognostic role of initial pan-endoscopic tumor length at diagnosis in operable esophageal squamous cell carcinoma undergoing esophagectomy with or without neoadjuvant concurrent chemoradiotherapy.Liposomal Co-Delivery of Omacetaxine Mepesuccinate and Doxorubicin for Synergistic Potentiation of Antitumor Activity
P2860
New and emerging combination therapies for esophageal cancer.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
New and emerging combination therapies for esophageal cancer.
@en
type
label
New and emerging combination therapies for esophageal cancer.
@en
prefLabel
New and emerging combination therapies for esophageal cancer.
@en
P2860
P356
P1476
New and emerging combination therapies for esophageal cancer.
@en
P2093
Joachim Mössner
Marcus W Wiedmann
P2860
P304
P356
10.2147/CMAR.S32199
P407
P577
2013-06-27T00:00:00Z